Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
Clinical trial NCT02764736 · WITHDRAWN
Trial details
- NCT number
- NCT02764736
- Sponsor
- Albert Einstein Healthcare Network
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-04
- Primary completion
- 2017-03-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.